Skip to main content
MLTX
NASDAQ Life Sciences

Sonelokimab Hits All Endpoints in Phase 3 Psoriatic Arthritis Trial, MoonLake Eyes Multi-Billion Dollar Market

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$18.9
Mkt Cap
$1.536B
52W Low
$5.95
52W High
$62.75
52W Position info
218% above low
Off High info
70% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MLTX has more than doubled off its 52-week low of $5.95.

Summary

MoonLake's sonelokimab met all primary and secondary endpoints in the Phase 3 IZAR-1 trial for psoriatic arthritis, with 42.1% of patients achieving ACR50 and strong results across skin, joint, and quality-of-life measures. The safety profile remains clean, with no new signals. This de-risks a second major indication beyond hidradenitis suppurativa and opens a multi-billion dollar market. The company ended Q2 with $537M in cash, extending runway to mid-2028, plus access to $400M in non-dilutive debt. Full 52-week data is expected in H1 2027, and the IZAR-2 trial in TNF-refractory patients completes enrollment in Q3 2026.

At the time of this announcement, MLTX was trading at $18.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $5.95 to $62.75. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

MLTX - Latest Insights

MLTX
Nov 04, 2026, 7:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.62
Real-time Price: $10.75 info
Change: -$0.870 (-7%) info
Market Cap: $919.152M info
MLTX
Nov 04, 2026, 7:07 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $10.75 info
Change: -$0.860 (-7%) info
Market Cap: $919.152M info
MLTX
Sep 30, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.81
Real-time Price: $10.75 info
Change: -$1.06 (-9%) info
Market Cap: $919.152M info
MLTX
Aug 10, 2026, 1:21 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $17.11
Real-time Price: $10.75 info
Change: -$6.36 (-37%) info
Market Cap: $919.152M info
MLTX
Aug 10, 2026, 7:46 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.19
Real-time Price: $10.75 info
Change: -$5.44 (-34%) info
Market Cap: $919.152M info